Medicine details

ImageTelcardis Plus 80
NameTelcardis Plus 80
DosageTablet
Generic NameHydrochlorothiazide + Telmisartan
Classes Cardiovascular Agent
Antihypertensive
Antihypertensive Combination
Diseases Cardiovascular Disease
Hypertension (High Blood Pressure)
CompanyUnimed & Unihealth Manufacturers Ltd.

Drug Package Details

Strength12.5 mg + 80 mg
Storage Condition
Origin CountryBangladesh
Commercial Pack14
Price per pack280.00
Cost per pack246.40
Package unit7 tabs strip
Price per unit20.00
Cost per unit17.60
Discount0
Coupon
Remarks

Hydrochlorothiazide + Telmisartan

Hydrochlorothiazide + Telmisartan is a combination of telmisartan, an orally active, AT1 receptor subtype specific angiotensin II receptor blocker (ARB), and hydrochlorothiazide, a diuretic.

This combination is used to treat Hypertension.

  • Hydrochlorothiazide + Telmisartan is available as oral tablets.
  • The recommended dose of Hydrochlorothiazide + Telmisartan for patients inadequately controlled with telmisartan monotherapy is 80 mg/12.5 mg. Dose can be titrated up to 160 mg/25 mg after 2 to 4 weeks, if necessary.
  • Start a patient on Hydrochlorothiazide + Telmisartan 80 mg / 12.5 mg once day if their blood pressure is not sufficiently controlled by 25 mg hydrochlorothiazide once daily, or if it is controlled but they have hypokalemia. If necessary, the dose can be increased to 160 mg/25 mg after 2 to 4 weeks.

The side effects associated with the medication are as follows-

  • headache
  • dizziness
  • Pharyngitis
  • Hypotension
  • Tinnitus
  • Dyspepsia
  • Asthenia
  • During the second and third trimesters of pregnancy, medications that act on the renin-angiotensin system impair fetal renal function and increase fetal and newborn morbidity and death.
  • In controlled trials, patients with uncomplicated hypertension treated with Hydrochlorothiazide + telmisartan experienced a very little (0.7 percent) drop in blood pressure. Symptomatic hypotension can occur in patients with an active renin-angiotensin system, such as volume- and/or salt-depleted patients on high doses of diuretics.

Contraindication

  •  Contraindicated to the patients who are sensitive to hydrochlorothiazide or to other sulfonamide-derived drugs, such as-
  • Contraindicated to the patients who are sensitive to telmisartan or other ARBs, such as-
  • Concomitant use of Hydrochlorothiazide + telmisartan with aliskiren containing products in patients with diabetes mellitus or renal impairment.
  • Hydrochlorothiazide + Telmisartan is contraindicated in patients with severe kidney problems (GFR 30 mL/min) and anuria due to the hydrochlorothiazide component.
  • Hydrochlorothiazide + Telmisartan is contraindicated in patients with significant hepatic problems or biliary cirrhosis and cholestasis due to the Telmisartan component.